Genentech’s Gavreto scores US approval for RET thyroid cancer
Precision therapy is designed to selectively target RET alterations
Read More
Tag: Gavreto
Genentech’s Gavreto cleared for RET non-small cell lung cancer
The personalised cancer treatment has received conditional approval in the US
Read More
- UCB and Cancer Research UK form expanded alliance to advance novel cancer therapies
- Calla Lily Clinical Care begins dosing in trial of intravaginal platform for threatened miscarriage
- Palisade Bio reports phase 1a/b data showing colon‑targeted exposure
- MimiVax and Roswell Park open phase 2 trial of SurVaxM for metastatic neuroendocrine tumours
- Myomaker Bio unveils lab‑grown human muscle platform to transform drug testing
